#scientific
BioMarin, Jazz Pharmaceuticals, and Otsuka CEOs to Join NORD CEO for High-Level Dialogue on Transforming Scientific Innovation Into Patient Progress
WASHINGTON, D.C. and NORWELL, Mass. — The National Organization for Rare Disorders (NORD®) has announced that CNBC “Squawk...
Turning Scientific Breakthroughs Into Patient Progress: Rare Disease Leaders to Headline NORD Breakthrough Summit
WASHINGTON, D.C. and NORWELL, Mass. — As scientific and technological advancements open unprecedented frontiers in medicine, turning laboratory...